Publicaciones (30) Publicaciones de Tomás Maira Litran

2024

  1. Targeting bacterial polysaccharides with antibodies and vaccines

    Methods in Microbiology (Academic Press Inc.), pp. 173-223

2017

  1. Complexity of complement resistance factors expressed by acinetobacter baumannii needed for survival in human serum

    Journal of Immunology, Vol. 199, Núm. 8, pp. 2803-2814

  2. Immunization of mice

    Current Protocols in Molecular Biology, Vol. 2017

2016

  1. Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi

    Cell

2014

  1. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood

    Pathogens and Disease, Vol. 70, Núm. 3, pp. 444-448

2013

  1. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 24

2012

  1. Evaluation of the trimeric autotransporter ata as a vaccine candidate against Acinetobacter baumannii infections

    Infection and Immunity, Vol. 80, Núm. 10, pp. 3381-3388

  2. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii

    Journal of Bacteriology, Vol. 194, Núm. 15, pp. 3950-3960

  3. Poly-n-acetyl-β-(1-6)-glucosamine is a target for protective immunity against acinetobacter baumannii infections

    Infection and Immunity, Vol. 80, Núm. 2, pp. 651-656

  4. Synthesis and Evaluation of a Conjugate Vaccine Composed of Staphylococcus aureus Poly-N-Acetyl-Glucosamine and Clumping Factor A

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. ACKNOWLEDGEMENT OF REVIEWERS

    Clinical Microbiology and Infection, Vol. 17, Núm. 1, pp. 102-103

  2. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice

    Infection and Immunity, Vol. 79, Núm. 8, pp. 3455-3464

2010

  1. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice

    Journal of Clinical Investigation, Vol. 120, Núm. 9, pp. 3220-3233

  2. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines

    Infection and Immunity, Vol. 78, Núm. 2, pp. 746-755

  3. Synthetic β-(1→6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens

    Infection and Immunity, Vol. 78, Núm. 2, pp. 764-772

2009

  1. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria

    Vaccine, Vol. 27, Núm. 17, pp. 2379-2386

  2. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation

    Journal of Bacteriology, Vol. 191, Núm. 19, pp. 5953-5963

2008

  1. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface

    Microbiology, Vol. 154, Núm. 3, pp. 865-877

2007

  1. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)- glucosamine

    Infection and Immunity, Vol. 75, Núm. 7, pp. 3406-3413

  2. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 18, pp. 7528-7533